NCT04521686 2026-04-22Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT06840886 2026-04-22A Study of PHST001 in Advanced Solid TumorsPheast TherapeuticsPhase 1 Recruiting272 enrolled
NCT03922555 2026-04-16ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant GliomasMassachusetts General HospitalPhase 1 Recruiting18 enrolled
NCT03911388 2026-04-13HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsM.D. Anderson Cancer CenterPhase 1 Recruiting24 enrolled
NCT04185038 2026-04-13Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsSeattle Children's HospitalPhase 1 Recruiting90 enrolled